EPISODE · Jul 25, 2025 · 19 MIN
Innovations in Manufacturing to Make CAR-T More Accessible and Affordable
from PharmaTalkRadio · host Conference Forum
Summary:Accessibility to CAR-T is limited by traditional manufacturing, with its associated challenges and high cost. Moffitt Cancer Center's Chief BioEngineering Officer, Dr Greg Sawyer, highlights Moffitt's significant progress in enhancing T cell potency and boosting efficacy through engineering strategies. Dr Sawyer discusses assays enabling precise asessment of T cell potency, developments in manufacturing, and more, and the resulting impact on scalability and efficiency. This presentation comes from the March 2025 Immuno-Oncology 360º Summit. For more information, go to IO360summit.com.
What this episode covers
Summary:Accessibility to CAR-T is limited by traditional manufacturing, with its associated challenges and high cost. Moffitt Cancer Center's Chief BioEngineering Officer, Dr Greg Sawyer, highlights Moffitt's significant progress in enhancing T cell potency and boosting efficacy through engineering strategies. Dr Sawyer discusses assays enabling precise asessment of T cell potency, developments in manufacturing, and more, and the resulting impact on scalability and efficiency. This presentation comes from the March 2025 Immuno-Oncology 360º Summit. For more information, go to IO360summit.com.
NOW PLAYING
Innovations in Manufacturing to Make CAR-T More Accessible and Affordable
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.